Species-specific inhibition of Giardia lamblia triosephosphate isomerase by localized perturbation of the homodimer

Molecular and Biochemical Parasitology

Volumn 157, Issue 2, 2008, Pages 179-186

  Enriquez Flores, Sergio ^a   Rodriguez Romero, Adela ^b   Hernandez Alcantara, Gloria ^a   De la Mora De la Mora, Ignacio ^a   Gutierrez Castrellon, Pedro ^a   Carvajal, Karla ^a   Lopez Velazquez, Gabriel ^a   Reyes Vivas, Horacio ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Giardia; Species specific inhibition; Thiol reagents; Triosephosphate isomerase

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); CYSTEINE; HOMODIMER; MONOMER; THIOMESYLIC ACID METHYL ESTER; TRIOSEPHOSPHATE ISOMERASE;

ARTICLE; CHEMICAL MODIFICATION; DISSOCIATION; DRUG DESIGN; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME STRUCTURE; GIARDIA LAMBLIA; NONHUMAN; PRIORITY JOURNAL; THERMOSTABILITY;

GIARDIA; GIARDIA INTESTINALIS;

EID: 38049125879     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2007.10.013     Document Type: Article

References (36)

1. Eckmann L. Mucosal defences against Giardia. Parasite Immunol 25 (2003) 259-270
2. Thompson R.C. Giardiasis as re-emerging infectious disease and its zoonotic potential. Int J Parasitol 30 (2000) 1259-1267
3. Gardner T.B., and Hill D.R. Treatment of giardasis. Clin Microbiol Rev 14 (2001) 114-128
4. Bost R.G. Metronidazole: mammalian mutagenicity. Proceedings of the International Metronidazole Conference, Montreal, Canada. Excerpta Medica, Amsterdam, The Netherlands (1977) 126-131
5. Lindmark D.G., and Muller M. Antitrichomonad action, mutagenecity, and reduction of metronidazole and other nitroimidazoles. Antimicrob Agents Chemother 10 (1976) 476-482
6. Upcroft J.A., Dunn L.A., Wright J.M., Benakli K., Upcroft P., and Vanelle P. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Antimicrob Agents Chemother 50 (2006) 344-347
7. Argüello-Garcia R., Cruz-Soto M., Romero-Montoya L., and Ortega-Pierres G. Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro. J Antimicrob Chemoter 54 (2004) 711-721
8. Eisenthal R., and Cornish-Bowden A. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness. J Biol Chem 273 (1998) 5500-5505
9. Subbayya I.N., Ray S.S., Balaram P., and Balaram H. Metabolic enzymes as potential drug targets in Plasmodium falciparum. Indian J Med Res 106 (1997) 79-94
10. Somoza J.R., Skillman Jr. A.G., Munagala N.R., et al. Rational design of novel antimicrobials: blocking purine salvage in a parasitic protozoan. Biochemistry 37 (1998) 5344-5348
11. Tovar J., León-Avila G., Sánchez L.B., et al. Mitochondrial remnant organelles of Giardia function in iron-sulphur protein maturation. Nature 426 (2003) 172-176
12. Schofiel P.J., Edwards M.R., and Kranz P. Glucose metabolism in Giardia intestinalis. Mol Biochem Parasitol 45 (1991) 39-48
13. López-Velázquez G., Molina-Ortiz D., Cabrera N., et al. An unusual triosephosphate isomerase from the early divergent Eukaryote Giardia lamblia. Proteins 55 (2004) 824-834
14. Reyes-Vivas H., Diaz A., Peon J., et al. Disulfide bridges in the mesophilic triosephosphate isomerase from Giardia lamblia are related to oligomerization and activity. J Mol Biol 365 (2007) 752-763
15. Kohlhoff M., Dahm A., and Hensel R. Tetrameric triosephosphate isomerase from hyperthermophilic Archaea. FEBS Lett 38 (1996) 250-345
16. Yu J.S., and Noll K.M. The hyperthermophilic bacterium Thermotoga neapolitana possesses two isozymes of the 3-phosphoglycerate kinase/triosephosphate isomerase fusion protein. FEMS Microbiol Lett 131 (1995) 307-312
17. Gómez-Puyou A., Saavedra-Lira E., Becker I., Zubillaga R.A., Rojo-Domínguez A., and Pérez-Montfort R. Using evolutionary changes to achieve species-specific inhibition of enzyme action. Studies with triosephosphate isomerase. Chem Biol 2 (1995) 847-855
18. Maldonado E., Soriano-García M., Moreno A., et al. Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes. J Mol Biol 283 (1998) 193-203
19. Maithal K., Ravindra G., Balaram H., and Balaram P. Inhibition of Plasmodium falciparum triose-phosphate isomerase by chemical modification of an interface cysteine. J Biol Chem 277 (2002) 25106-25114
20. Rodríguez-Romero A., Hernández-Santoyo A., Yauner L.P., Kornhauser A., and Fernández-Velasco D.A. Structure and inactivation of triosephosphate isomerase from Entamoeba histolytica. J Mol Biol 322 (2002) 669-675
21. Mande S.C., Mainfroid V., Kalk K.H., Goraj K., Martial J.A., and Hol W.G. Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase related human genetic disorders and comparison with the trypanosomal enzyme. Protein Sci 3 (1994) 810-821
22. Penefsky H.S. Reversible binding of Pi by beef heart mitochondrial adenosine triphosphatase. J Biol Chem 252 (1977) 2891-2899
23. Ellman G.L. A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys 74 (1958) 443-450
24. Hernández-Alcántara G., Garza-Ramos G., Mendoza-Hernández G., Gómez-Puyou A., and Pérez-Montfort R. Catalysis and stability of triosephosphate isomerase from Trypanosoma brucei with different residues at position 14 of the dimer interface. Characterization of a catalytically competent monomeric enzyme. Biochemistry 41 (2002) 4230-4238
25. Hubbard SJ, Thornton JM. NACCESS, computer program. London: Department of Biochemistry and Molecular Biology, University College London; 1993.
26. Hubbard S.J., Campbell S.F., and Thornton J.M. Molecular recognition. Conformational analysis of limited proteolytic sites and serine proteinase protein inhibitors. J Mol Biol 220 (1991) 507-530
27. Creighton T.E. Protein structure (1996), Oxford University Press, New York
28. Garza-Ramos G., Pérez-Montfort R., Rojo-Domínguez A., Tuena de Gómez-Puyou M., and Gómez-Puyou A. Species-specific inhibition of homologous enzymes by modification of nonconserved amino acids residues. The cysteine residues of triosephosphate isomerase. Eur J Biochem 241 (1996) 114-120
29. Garza-Ramos G., Tuena de Gómez-Puyou M., Gómez-Puyou A., and Gracy R.W. Dimerization and reactivation of triosephosphate isomerase in reverse micelles. Eur J Biochem 208 (1992) 389-395
30. Waley S.G. Refolding of triosephosphate isomerase. Biochem J 135 (1973) 165-172
31. Zabori S., Rudolph F., and Jaenicke R. Folding and association of triosephosphate isomerase from rabbit muscle. Z Naturforsch 35 (1980) 999-1004
32. Schliebs W., Thanki N., Eritja R., and Wierenga R. Active site properties of monomeric triosephosphate isomerase (monoTIM) as deduced from mutational and structural studies. Protein Sci 5 (1996) 229-239
33. Gnerer J.P., Kreber R.A., and Ganetzky B. Wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death. PNAS 103 (2006) 14987-14993
34. Garza-Ramos G., Cabrera N., Saavedra-Lira E., et al. Sulfhydryl reagent susceptibility in proteins with high sequence similarity triosephosphate isomerase from Trypanosoma brucei, Trypanosoma cruzi and Leishmania mexicana. Eur J Biochem 253 (1998) 684-691
35. Russell R.B., and Barton G.J. Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins 14 (1992) 309-323
36. Humprey W., Dalke A., and Schulten K. VMD: visual molecular dynamics. J Mol Graph 14 (1996) 33-38